A usage-safety study of two new, dry skin formulations in patients with atopic dermatitis.
A usage-safety study involving two new dry skin formulations was conducted using a group of subjects with a history of atopic dermatitis. The results indicate that these formulations are safe in persons with inactive to mildly active dermatitis and are effective in alleviating the signs of dry skin, particularly on the legs. However, one individual with very active dermatitis developed an irritant reaction to one test formulation, possibly related to the fragrance contained therein.
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D003876:Dermatitis, Atopic / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010577:Petrolatum / Q000008:administration & dosage*
D010577:Petrolatum